POLAREAN, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.polarean.com
Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging
Phase 1
Recruiting
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Device: Vibrating Mesh NebulizerDevice: Metered Dose InhalerDevice: Jet Nebulizer
- First Posted Date
- 2024-02-21
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Polarean, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT06271408
- Locations
- 🇺🇸
University of Virginia Sheridan Snyder Translational Fontaine Research Unit, Charlottesville, Virginia, United States
Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant
Phase 3
Completed
- Conditions
- Pulmonary Surgical Procedures
- Interventions
- Drug: 133XE scintigraphy
- First Posted Date
- 2018-02-01
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- Polarean, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT03418090
- Locations
- 🇺🇸
Duke University Hospital, Durham, North Carolina, United States
🇺🇸University of Virginia, Charlottesville, Virginia, United States
Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection
Phase 3
Completed
- Conditions
- Pulmonary Surgical Procedures
- Interventions
- Drug: 133 Xe scintigraphy
- First Posted Date
- 2018-01-31
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Polarean, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT03417687
- Locations
- 🇺🇸
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
🇺🇸Duke University Hospital, Durham, North Carolina, United States
🇺🇸University of Virginia, Charlottesville, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath